🐾 Apoquel tablets 3.6 mg, 100 pcs.

Apoquel belongs to the group of selective Janus Kinase Inhibitors (JAK) drugs.

Oclacitinib maleate, a component of the drug, inhibits the functions of proinflammatory, proallergic and pruritogenic (pruritogenic) cytokines dependent on the enzymatic activity of Janus kinase JAK1 or JAK3 at a therapeutic dose, the targeted effect on which allows to inhibit key mechanisms of itching associated with allergy and helps to eliminate the symptoms of local inflammation; cytokines involved in hematopoiesis and dependent on JAK2 are not significantly affected.

After oral administration oclacytinib maleate is quickly absorbed in gastro-intestinal tract (bioavailability is 89 %), enters systemic blood flow, achieving maximal concentration in plasma in less than 1 hour, penetrates into most organs and tissues, is practically not metabolized, is excreted unchanged, mainly with urine, elimination half-life is 3-4 hours.

Apokvel is classified as moderately hazardous substances (3 class of hazard according to GOST 12.1.007) with weakly expressed cumulative properties; in recommended dose it does not exhibit mutagenic, carcinogenic, embryotoxic and teratogenic activity.

Indications

Active ingredient

Composition

How to take, the dosage

Special Instructions

Contraindications

Side effects